Literature DB >> 22877648

The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis.

Seul Ki Lim1, Soo Hyun Park.   

Abstract

AIMS: We examined renal kallikrein-kinin system (KKS) apoptosis and its related signaling pathway in rat podocytes. In addition, we studied the relationship of cannabinoid receptor 1 (CB(1)R) with high glucose and BK receptors. MAIN
METHODS: Cell viability was determined by an MTT assay and apoptosis by DNA fragmentation assay, while gene expression was investigated by RT-PCR. Protein expression was analyzed by Western blot analysis. A chemical inhibitor or siRNA transfection was used to inhibit B1R, B2R, and CB(1)R signaling. KEY
FINDINGS: High glucose (25 mM) treatment decreased cell viability and increased DNA fragmentation. High glucose-induced DNA fragmentation and PARP and caspase-3 activations were blocked by both [des-Arg(10)]-HOE 140 (a B1R antagonist) and HOE 140 (a B2R antagonist). High glucose also increased Akt phosphorylation, ER stress-related protein expression, and NF-κB/I-κB phosphorylation in podocytes, which was blocked by both [des-Arg(10)]-HOE 140 and HOE 140. In addition, B1R and B2R siRNA transfections prevented high glucose-induced Akt and NF-κB activations in rat podocytes. Moreover, AM251 (a CB(1)R antagonist) treatment and CB(1)R siRNA transfection blocked the high glucose-induced stimulation of BK receptor expression, Akt activation, and NF-κB activation. SIGNIFICANCE: Our study suggests that hyperglycemia induces apoptosis via the stimulation of B1R and B2R expression through CB(1)R activation in rat podocytes in vitro, which is associated with the development of diabetic nephropathy.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22877648     DOI: 10.1016/j.lfs.2012.07.020

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  New insights into the pathology of podocyte loss: mitotic catastrophe.

Authors:  Helen Liapis; Paola Romagnani; Hans-Joachim Anders
Journal:  Am J Pathol       Date:  2013-09-03       Impact factor: 4.307

2.  Novel Targets for Therapy of Renal Fibrosis.

Authors:  Niki Prakoura; Juliette Hadchouel; Christos Chatziantoniou
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

3.  Kinin B1 receptor deficiency attenuates cisplatin-induced acute kidney injury by modulating immune cell migration.

Authors:  Gabriel R Estrela; Frederick Wasinski; Danilo C Almeida; Mariane T Amano; Angela Castoldi; Carolina C Dias; Denise M A C Malheiros; Sandro S Almeida; Edgar J Paredes-Gamero; João B Pesquero; Carlos C Barros; Niels O S Câmara; Ronaldo C Araújo
Journal:  J Mol Med (Berl)       Date:  2013-12-20       Impact factor: 4.599

4.  Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics.

Authors:  Masanori Hara; Kazuhiko Oohara; Dao-Fu Dai; Helen Liapis
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

5.  Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

Authors:  Tony Jourdan; Gergő Szanda; Avi Z Rosenberg; Joseph Tam; Brian James Earley; Grzegorz Godlewski; Resat Cinar; Ziyi Liu; Jie Liu; Cynthia Ju; Pál Pacher; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 6.  Cannabinoids and the kidney: effects in health and disease.

Authors:  Frank Park; Praveen K Potukuchi; Hamid Moradi; Csaba P Kovesdy
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-26

Review 7.  Anandamide and its metabolites: what are their roles in the kidney?

Authors:  Joseph K Ritter; Guangbi Li; Min Xia; Krishna Boini
Journal:  Front Biosci (Schol Ed)       Date:  2016-06-01

Review 8.  Modes of podocyte death in diabetic kidney disease: an update.

Authors:  Anni Jiang; Anni Song; Chun Zhang
Journal:  J Nephrol       Date:  2022-02-24       Impact factor: 4.393

9.  Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.

Authors:  Shiran Udi; Liad Hinden; Brian Earley; Adi Drori; Noa Reuveni; Rivka Hadar; Resat Cinar; Alina Nemirovski; Joseph Tam
Journal:  J Am Soc Nephrol       Date:  2017-08-31       Impact factor: 10.121

Review 10.  Cannabinoid Receptors in Diabetic Kidney Disease.

Authors:  F Barutta; R Mastrocola; S Bellini; G Bruno; Gabriella Gruden
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.